Oxford, AstraZeneca resume COVID vaccine trial after reported side effect

LONDON — Oxford University announced Saturday it was resuming a trial for a coronavirus vaccine it is developing with pharmaceutical company AstraZeneca, a move that comes days after the study was suspended following a reported side effect in a U.K. patient.

In a statement, the university confirmed the restart across all of its U.K. clinical trial sites after regulators gave the go-ahead following the pause on Sunday.

Although Oxford would not disclose information about the patient’s illness due to participant confidentiality, an AstraZeneca spokesman said earlier this week that a woman had developed severe neurological symptoms that prompted the pause. Specifically, the woman is said to have developed symptoms consistent with transverse myelitis, a rare inflammation of the spinal cord. Authorities: 1 dead in shooting at northern Indiana shopping mall MISHAWAKA, Ind. — A shooting at a northern Indiana mall left one person dead and sent shoppers running for safety, authorities said.

St. Joseph County Coroner Michael McGann said Saturday evening that one person was killed in the shooting about 3 p.m. at University Park Mall in Mishawaka. He did not release further details.

Police also did not release information on a possible shooting suspect.

The shooting prompted the evacuation of the mall in the city just east of South Bend. Another coronavirus consequence: No Peeps until Easter

BETHLEHEM, Pa. — Peeps treats are going on hiatus for several months — another consequence of the coronavirus pandemic.

Just Born Quality Confections said it won’t be producing the popular marshmallow sweets for Halloween, Christmas or Valentine’s Day as the Bethlehem, Pennsylvaniabased company prepares for next Easter, PennLive.com reports.